SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 4,104.41 |
Enterprise Value ($M) | 4,807.35 |
Book Value ($M) | 353.83 |
Book Value / Share | 3.83 |
Price / Book | 11.60 |
NCAV ($M) | -424.04 |
NCAV / Share | -4.60 |
Price / NCAV | -9.68 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.45 |
Return on Assets (ROA) | -0.38 |
Return on Equity (ROE) | -17.95 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.24 |
Current Ratio | 2.37 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 817.12 |
Assets | 1,503.46 |
Liabilities | 1,241.16 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 560.23 |
Operating Income | -535.97 |
Net Income | -569.18 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -414.19 |
Cash from Investing | -17.77 |
Cash from Financing | 399.24 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Sands Capital Management, Llc | |||
13G/A | Wellington Management Group Llp | |||
13G/A | Rtw Investments, Lp | 2.10 | -71.42 | |
13G/A | Price T Rowe Associates Inc /md/ | 4.20 | -15.69 | |
13G/A | Vanguard Group Inc | 10.56 | 19.86 | |
13G/A | BlackRock, Inc. | 6.40 | 20.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
124,773 | 474,567 | 26.29 | |
126,213 | 487,225 | 25.90 | |
116,129 | 604,414 | 19.21 | |
132,621 | 644,595 | 20.57 | |
(click for more detail) |
Similar Companies | |
---|---|
QDEL – QuidelOrtho Corporation | QNCX – Quince Therapeutics, Inc. |
QURE – uniQure N.V. | RDUS – Radius Recycling, Inc. |
REGN – Regeneron Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io